Employing an assumption that BDNF Val66Met polymorphism influences the severity and recovery of aphasia, identifying specific alleles of BDNF as a predictor for aphasia severity and recovery may be the next step targeting selective therapeutic strategies in stroke patients. This evidence concerns the gene BDNF and Aphasia.